BRIEF published on 05/02/2025 at 01:55, 10 months 14 days ago BioNxt Solutions Delays 2024 Annual Financial Statement Filing Management Cease Trade Order Healthcare Innovation Financial Statements Delay Annual Filings BioNxt Solutions
PRESS RELEASE published on 05/02/2025 at 01:50, 10 months 14 days ago BioNxt Solutions Announces Delay In Filing 2024 Annual Financial Statements BioNxt Solutions Inc. announces delay in filing annual financial statements for year ended December 31, 2024. Company working on completing filings by June 28, 2025, under management cease trade order Financial Statements Management Cease Trade Order BioNxt Solutions Inc. Delay Regulatory Authorities
BRIEF published on 04/23/2025 at 09:10, 10 months 23 days ago BioNxt Solutions Advances in MS Treatment Study Multiple Sclerosis Cladribine Drug Delivery Innovation BioNxt Solutions Bioequivalence Study
PRESS RELEASE published on 04/23/2025 at 09:05, 10 months 23 days ago BioNxt Solutions Prepares for Human Bioequivalence Study For MS BioNxt Solutions Inc. reports advanced preparation for human bioequivalence study of BNT23001, a novel sublingual thin-film Cladribine formulation for Multiple Sclerosis treatment BioNxt Solutions Inc. Multiple Sclerosis Treatment Sublingual Thin-Film BNT23001 Human Bioequivalence Study
BRIEF published on 03/15/2025 at 00:05, 1 year ago BioNxt Solutions Closes Final Tranche of Convertible Debenture Offering Private Placement Convertible Debenture Warrants Financing BioNxt Solutions
PRESS RELEASE published on 03/15/2025 at 00:00, 1 year ago BioNxt Solutions Announces Closing of Final Tranche of Fully Subscribed Convertible Debenture Unit Private Placement BioNxt Solutions Inc. completes final tranche of convertible debenture Offering for $900,000. Funds to be used for product dev, IP, debt repayment, and working capital Private Placement Convertible Debenture Healthcare BioNxt Solutions Inc. Drug Delivery Technologies
BRIEF published on 03/01/2025 at 01:40, 1 year ago BioNxt Solutions Secures $1.6 Million in Convertible Debenture Private Placement Private Placement Convertible Debenture Investment BioNxt Solutions Proceeds Utilization
PRESS RELEASE published on 03/01/2025 at 01:35, 1 year ago BioNxt Solutions Announces Closing of First Tranche of Convertible Debenture Unit Private Placement BioNxt Solutions Inc. closes first tranche of convertible debenture units Offering, raising $1.6M. Proceeds for product development, IP filings, debt repayment, and working capital Private Placement BioNxt Solutions Inc. Intellectual Property Product Development Convertible Debenture Units
BRIEF published on 02/24/2025 at 15:05, 1 year ago BioNxt Solutions Launches Debenture Unit Financing Private Placement Regulatory Approvals Convertible Securities Debenture Units Compensation Warrants
PRESS RELEASE published on 02/24/2025 at 15:00, 1 year ago BioNxt Solutions Announces Debenture Unit Financing BioNxt Solutions Inc. announces a non-brokered private placement of debenture units and Finders Warrants, expecting gross proceeds of up to $2,500,000, subject to regulatory approvals Private Placement BioNxt Solutions Inc. Regulatory Approvals Debenture Units Finders Warrants
Published on 03/15/2026 at 23:25, 11 hours 15 minutes ago Tunkillia 'Phase 2' Resource Upgrade Drilling Begins
Published on 03/15/2026 at 18:00, 16 hours 40 minutes ago SEG Announced 2025 Annual Results Initiating First Special Dividend Distribution Payout Ratio Reached 88% Newly Signed Orders Exceeded RMB100-Billion Mark for the Second Consecutive Year
Published on 03/13/2026 at 23:00, 2 days 11 hours ago CORRECTION FROM SOURCE: EV Nickel Announces Maiden Mineral Resource Estimate for Gemini North Nickel Zone
Published on 03/13/2026 at 23:00, 2 days 11 hours ago Redwood AI Announces Platform Name Change and Appointment of Dr. Mark Dybul as Public Safety & Defense Advisor
Published on 03/13/2026 at 21:30, 2 days 13 hours ago Alset AI Announces Closing of Shares for Debt Transaction
Published on 03/16/2026 at 10:35, 5 minutes ago Piramal Pharma Solutions' Grangemouth, UK Facility Successfully Delivers 1,500th ADC Batch
Published on 03/16/2026 at 10:20, 20 minutes ago EightSix Launches Brand Studio: The World's First Brand Music Intelligence System
Published on 03/16/2026 at 10:15, 25 minutes ago NVision and Aarhus University Awarded Innovation Fund Denmark Grant to Advance Clinical Translation of Quantum-Enhanced MRI
Published on 03/16/2026 at 10:05, 35 minutes ago AliExpress Anniversary Sale Hits up to 90% Off as Brand+ Channel Surges with Exclusive Tech Debuts and Price Guarantee
Published on 03/16/2026 at 10:00, 40 minutes ago REPLOID launches crowdfinancing campaign on Invesdor
Published on 03/16/2026 at 08:30, 2 hours 10 minutes ago CDA - Update on CDA' parks solarization program
Published on 03/13/2026 at 19:50, 2 days 14 hours ago Availability of ENGIE’S 2025 Universal Registration Document
Published on 03/13/2026 at 18:05, 2 days 16 hours ago Availability of the 2025 Universal Registration Document of OPmobility SE
Published on 03/13/2026 at 07:30, 3 days 3 hours ago BIOPHYTIS PRESENTS ITS DEVELOPMENT PROGRAMS IN OBESITY AND SARCOPENIA AT THE ICFSR CONFERENCE
Published on 03/12/2026 at 18:00, 3 days 16 hours ago NEW OR RENEWED AGREEMENTS BETWEEN EURAZEO AND CERTAIN FAMILY SHAREHOLDERS
